PubRank

Caterina Uberti-Foppa

Author PubWeight™ 22.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J Clin Microbiol 2003 1.75
2 Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 2002 1.70
3 Surgical site infections after elective neurosurgery: a survey of 1747 patients. Neurosurgery 2008 1.66
4 Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr 2006 1.09
5 Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. J Acquir Immune Defic Syndr 2009 1.05
6 Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood 2006 1.03
7 Patients presenting with AIDS in the HAART era: a collaborative cohort analysis. AIDS 2008 1.02
8 Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis 2005 0.94
9 Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis. PLoS One 2011 0.91
10 Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. AIDS 2003 0.86
11 Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment. J Antimicrob Chemother 2007 0.86
12 Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients. Hepat Mon 2011 0.85
13 Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2009 0.82
14 Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy. New Microbiol 2007 0.81
15 Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. J Acquir Immune Defic Syndr 2009 0.81
16 Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases. J Acquir Immune Defic Syndr 2010 0.80
17 A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients. PLoS One 2013 0.79
18 Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs. Liver Int 2013 0.78
19 Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy. Antivir Ther 2006 0.78
20 Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin. Medicine (Baltimore) 2015 0.77
21 HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study). New Microbiol 2012 0.77
22 Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels. New Microbiol 2007 0.76
23 Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease. New Microbiol 2014 0.76
24 Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report. J Med Case Rep 2009 0.75
25 Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus. J Antimicrob Chemother 2013 0.75
26 Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women. J Antimicrob Chemother 2006 0.75
27 Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients. New Microbiol 2011 0.75